- Home
- News
- latamerica
- implant functionalization
Implant Functionalization Articles & Analysis
15 news found
(“Anuncia” or the “Company”), a Company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF) management systems, is pleased to announce the successful first implant of the Company’s FDA-cleared ReFlow™ Mini Flusher device in tandem with a “sonolucent” cranial plate ...
While the advent of personalized bone implants provides a treatment pathway that can drastically improve the quality of life for many of these patients. ...
ByCELLINK
Active Implants, LLC, a company that develops orthopedic implant solutions, today announced enrollment of the 100th patient in clinical trials evaluating the NUsurface® Meniscus Implant for the treatment of persistent knee pain caused by injured or deteriorating meniscus tissue. ...
Hacker is the only physician in San Diego County – and Grossmont Orthopedic Medical Group is one of just 10 sites nationwide – enrolling patients with persistent knee pain caused by injured or deteriorating meniscus cartilage in the SUN trial, which is designed to assess the ability of the NUsurface Meniscus Implant (pronounced “new surface”) in restoring ...
Active Implants, LLC, a developer of orthopedic implant solutions for joint preservation, today announced that the NUsurface® Meniscus Implant has been granted a Breakthrough Device Designation from the U.S. ...
Active Implants, a company that develops orthopedic implant solutions, today announced that the company’s SUN (Safety Using NUsurface) trial is now underway in San Diego. ...
The findings were presented at the European Society of Cardiology Heart Failure meeting by Spanish structural heart disease expert, Professor Julio Nunez from the University of Valencia. Patients were implanted with the shunt during a minimally invasive procedure and were discharged home the next day. ...
Active Implants LLC, a company that develops orthopedic implant solutions, today announced that two patients in Israel have undergone knee surgery for the company’s NUsurface® Meniscus Implant – the first “artificial meniscus” to be marketed in the Middle East. ...
Horst Schmidt Kliniken Wiesbaden in Germany was the first hospital outside the United States to offer the Company’s PROPEL® Contour (mometasone furoate) sinus implant following functional endoscopic sinus surgery (FESS). FESS is used to treat chronic rhinosinusitis, a persistent inflammation of the sinuses that can be debilitating to patients. ...
Results of the study include: 84% of patients treated with the NUsurface Implant experienced a 10-point improvement from baseline in Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain, which is considered the minimum clinically relevant improvement in pain and function. 89% of patients who received the NUsurface Implant completed 24 ...
Active Implants LLC, a company that develops orthopedic implant solutions, today announced that the final patient was treated in the two clinical trials evaluating the NUsurface Meniscus Implant for the treatment of persistent knee pain caused by injured or deteriorated meniscus tissue. ...
« Being able to design and build tissues niche-by-niche opens up unprecedented possibilities for controlling quality features in engineered living implants for skeletal defect regeneration. The automation capacity of Poietis’ technology can be also seen as the end-stage unit operation in the production pipeline of GMP compliant tissue products”, commented Dr. ...
ByPoietis
Another recent revision procedure resulted in a successful implantation of a functioning H2 ankle to a previously fused ankle due to a mal-alignment from failed arthrodesis surgery. ...
Our devices are based on our platform STAR® technology which provides substrate independent, precision-engineered, 3D biomaterial scaffolds that enhance the bio-integration and function of medical implants. This patented technology is already in human use as an implant for glaucoma treatment, and has shown promising preclinical results for a ...
TOCA is the only center in the state – and one of just 10 sites nationwide – enrolling patients with persistent knee pain caused by injured or deteriorating meniscus cartilage in the SUN trial, which is designed to assess the safety and effectiveness of the NUsurface® Meniscus Implant (pronounced “new surface”) in restoring function ...